Catecholamines potentiate LPS‐induced expression of MMP‐1 and MMP‐9 in human monocytes and in the human monocytic cell line U937: possible implications for peri‐ operative plaque instability
暂无分享,去创建一个
Gerald Maurer | G. Maurer | K. Huber | J. Wojta | C. Kaun | S. Pfaffenberger | Helfried Metzler | Kurt Huber | H. Metzler | W. Toller | Johann Wojta | W. Speidl | T. Weiss | S. Kastl | Stefan Pfaffenberger | Walter S Speidl | Wolfgang G Toller | Christoph Kaun | Thomas W Weiss | Stefan P Kastl | Alexander Furnkranz | A. Furnkranz
[1] J. Westermarck,et al. Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] L Goldman,et al. Cardiac Risk in Noncardiac Surgery: An Update , 1995, Anesthesia and analgesia.
[3] V. Fuster,et al. Coronary plaque disruption. , 1995, Circulation.
[4] P. Libby,et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[5] U. Shankavaram,et al. Lipopolysaccharide induction of monocyte matrix metalloproteinases is regulated by the tyrosine phosphorylation of cytosolic phospholipase A2 , 1998, Journal of leukocyte biology.
[6] E. Vellenga,et al. Interleukin-4 inhibits the lipopolysaccharide-induced expression of c-jun and c-fos messenger RNA and activator protein-1 binding activity in human monocytes. , 1993, Blood.
[7] T. Ueno,et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. , 1998, Journal of the American College of Cardiology.
[8] S. Shapiro,et al. Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. , 1991, Journal of immunology.
[9] L. Fleisher,et al. Clinical practice. Lowering cardiac risk in noncardiac surgery. , 2001, The New England journal of medicine.
[10] L. Fleisher,et al. LOWERING CARDIAC RISK IN NONCARDIAC SURGERY , 2001 .
[11] A. Hannekum,et al. Endotoxemia and Mediator Release During Cardiac Surgery , 2000, Angiology.
[12] J. Roman,et al. Induction of MMP-9 mediated gelatinolytic activity in human monocytic cells by cell wall components of Mycobacterium tuberculosis. , 2000, Microbial pathogenesis.
[13] E. Zandi,et al. AP-1 function and regulation. , 1997, Current opinion in cell biology.
[14] K. Gardiner,et al. Intestinal manipulation during elective aortic aneurysm surgery leads to portal endotoxaemia and mucosal barrier dysfunction. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[15] B. Schmierer,et al. Catecholamines up‐regulate lipopolysaccharide‐induced IL‐6 production in human microvascular endothelial cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] E F Cook,et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.
[17] W. Browner,et al. Association of Perioperative Myocardial Ischemia with Cardiac Morbidity and Mortality in Men Undergoing Noncardiac Surgery , 1990 .
[18] E. Braunwald. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.
[19] D. Celermajer,et al. Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages. , 2002, Journal of the American College of Cardiology.
[20] R. Pierce,et al. Monocytic cell type-specific transcriptional induction of collagenase. , 1996, The Journal of clinical investigation.
[21] J. Isner,et al. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. , 1995, Circulation.
[22] A. Wallace,et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.
[23] allace,et al. EFFECT OF ATENOLOL ON MORTALITY AND CARDIOVASCULAR MORBIDITY AFTER NONCARDIAC SURGERY , 2000 .
[24] P. Libby,et al. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] J. Roman,et al. Induction of MMP-9 mediated gelatinolytic activity in human monocytic cells by cell wall components of M. tuberculosis , 2000 .
[26] K. Chung,et al. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. , 2000, American journal of respiratory and critical care medicine.
[27] Markus Schwaninger,et al. A mechanism converting psychosocial stress into mononuclear cell activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. Virmani,et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.
[29] M. Seidelmann,et al. Endotoxemia and acute-phase proteins in major abdominal surgery. , 2001, American journal of surgery.
[30] V. Fuster,et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. , 1995, Circulation.
[31] Gries,et al. Perioperative catecholamine changes in cardiac risk patients , 1999, European journal of clinical investigation.
[32] K. Huber,et al. Effect of Glycoprotein IIb/IIIa Antagonist Abciximab on Monocyte-Platelet Aggregates and Tissue Factor Expression , 2003, Arteriosclerosis, thrombosis, and vascular biology.